Literature DB >> 17160549

Estimation of the levels of D-dimer by use of an alternative method based in the reaction time of fibrinogen/fibrin degradation products assay.

Rafael Noal Moresco1, Luis Cláudio Rosa Vargas, Lúcia Silla.   

Abstract

BACKGROUND: D-dimer and fibrinogen/fibrin degradation products (FDP) levels are elevated in thromboembolic disorders, and its assays are used in many laboratories for the investigation of these disorders. The aim of this study was to propose a cost saving alternative method for determination of D-dimer levels based in the reaction time of FDP assay.
METHODS: D-dimer and FDP immunoassays were performed in 100 blood samples from subjects by use of Liatest D-dimer and Plasma FDP. The results of D-dimer obtained by the Liatest D-dimer were compared with the results obtained by the estimation method.
RESULTS: A significant association between D-dimer levels and the reaction times necessary to occur agglutination in latex agglutination test for FDP was observed. A close agreement between D-dimer results obtained by the Liatest D-dimer and by the estimation method (D-dimer = 82829 FDPt(-0.8683)) was observed.
CONCLUSIONS: The estimation method described in this study could be useful for clinical laboratories because it allows estimating the D-dimer levels before of the automated systems analysis, reducing costs associated to dilutions of plasma samples and reagents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160549     DOI: 10.1007/s11239-006-9044-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   5.221


  18 in total

1.  D-dimer testing for suspected pulmonary embolism in outpatients.

Authors:  A Perrier; S Desmarais; C Goehring; P de Moerloose; A Morabia; P F Unger; D Slosman; A Junod; H Bounameaux
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

2.  Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.

Authors:  Rafael Noal Moresco; Ronald Halla Júnior; Luis Cláudio Rosa Vargas; Lúcia Mariano da Rocha Silla
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

3.  Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis (Liatest D-dimer).

Authors:  M Escoffre-Barbe; E Oger; C Leroyer; M Grimaux; E Le Moigne; M Nonent; L Bressollette; J F Abgrall; C Soria; J Amiral; P Ill; J Clavier; D Mottier
Journal:  Am J Clin Pathol       Date:  1998-06       Impact factor: 2.493

4.  A new quantitative D-dimer assay appropriate in emergency: reliability of the assay for pulmonary embolism exclusion diagnosis.

Authors:  M Duet; S Benelhadj; W Kedra; D Vilain; C Ajzenberg; D Elkharrat; L Drouet; C Soria; O Mundler
Journal:  Thromb Res       Date:  1998-07-01       Impact factor: 3.944

5.  Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism.

Authors:  H Bounameaux; P Cirafici; P de Moerloose; P A Schneider; D Slosman; G Reber; P F Unger
Journal:  Lancet       Date:  1991-01-26       Impact factor: 79.321

6.  Efficacy of D-dimer and total fibrin degradation products evaluation in suspected pulmonary embolism.

Authors:  J Flores; C Lancha; E Pérez Rodríguez; A García Avello; E Bollo; L J García Frade
Journal:  Respiration       Date:  1995       Impact factor: 3.580

7.  Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis.

Authors:  Hyun Kyung Kim; Kyoung Rhan Lee; Jeon Ho Yang; Sung Jae Yoo; Sang Won Lee; Hyun-Jung Jang; Sang Jae Park; Young-Soo Moon; Joong-Won Park; Chang-Min Kim
Journal:  Thromb Res       Date:  2003-01-25       Impact factor: 3.944

Review 8.  Plasma D-dimers in the diagnosis of venous thromboembolism.

Authors:  James Kelly; Anthony Rudd; Roger R Lewis; Beverley J Hunt
Journal:  Arch Intern Med       Date:  2002-04-08

9.  D-dimer levels and risk of recurrent venous thromboembolism.

Authors:  Sabine Eichinger; Erich Minar; Christine Bialonczyk; Mirko Hirschl; Peter Quehenberger; Barbara Schneider; Ansgar Weltermann; Oswald Wagner; Paul A Kyrle
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272

10.  Elevated concentrations of cross-linked fibrin degradation products in plasma. An early marker of gram-negative bacteremia.

Authors:  S R Deitcher; P R Eisenberg
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.